Identical exposure is obtained with subcutaneous administration of semaglutide within the abdomen, thigh, or higher arm. A significant hypersensitivity reaction to semaglutide or to any with the excipients in copyright. Significant hypersensitivity reactions including anaphylaxis and angioedema have already been claimed with copyright [see WARNI